You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glutamate agonist

Showing 1 - 25 of 2,087
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical High Risk for Psychosis Trial in New York (Pomaglumetad methionil)

Completed
Has Results
  • Clinical High Risk for Psychosis
  • Pomaglumetad methionil
  • New York, New York
    New York State Psychiatric Institute
Nov 5, 2021

Delirium Trial in Birmingham (Guanfacine, Placebo)

Recruiting
  • Delirium
  • Birmingham, Alabama
    University of Alabama at Birmingham Hospital
Nov 17, 2021

Autism Spectrum Disorder Trial in Columbia (Memantine, Magnetic Resonance Imaging)

Completed
  • Autism Spectrum Disorder
  • Columbia, Missouri
    University of Missouri
Apr 9, 2021

Cancer Pain, Adenocarcinoma Trial in Ottawa (Methadone, Morphine)

Withdrawn
  • Cancer Pain
  • Adenocarcinoma
  • (no location specified)
Dec 1, 2022

Psychosis, Schizophrenia, Schizoaffective Disorder Trial in New York (ceftriaxone, Normal Saline)

Terminated
Has Results
  • Psychosis
  • +2 more
  • New York, New York
    NYS Psychiatric Institute
Dec 14, 2021

Depression Trial in Atlanta (Infliximab, Placebo)

Active, not recruiting
  • Depression
  • Atlanta, Georgia
    Emory University
Jan 23, 2023

Brain Injuries, Traumatic Trial (Glutamine, Placcebo)

Not yet recruiting
  • Brain Injuries, Traumatic
  • (no location specified)
Oct 5, 2022

Dexmedetomidine, Ketamine, Analgesia Trial in Nanjing (Esketamine combined with dexmedetomidine, Dexmedetomidine)

Not yet recruiting
  • Dexmedetomidine
  • +4 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jul 18, 2022

Post-mastectomy Pain Syndrome Trial in Cairo (Pregabalin, Tianeptine)

Recruiting
  • Post-mastectomy Pain Syndrome
  • Cairo, Egypt
    National Cancer Institute Cairo University
Jul 6, 2023

Peripheral Artery Disease Trial in Omaha (Supervised exercise therapy)

Not yet recruiting
  • Peripheral Artery Disease
  • Supervised exercise therapy
  • Omaha, Nebraska
    Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Aug 24, 2023

MDD, Treatment Resistant Depression, Bipolar Depression Trial in Rochester (Ketamine)

Enrolling by invitation
  • Major Depressive Disorder
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 12, 2022

Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)

Completed
Has Results
  • Lung Carcinoma
  • +2 more
  • Computed Tomography
  • +5 more
  • Nashville, Tennessee
  • +1 more
Oct 17, 2022

Cocaine Use Disorder, Opioid Use Disorder Trial in Lexington (n-acetylcysteine, Hydromorphone, Placebo n-acetylcystine)

Recruiting
  • Cocaine Use Disorder
  • Opioid Use Disorder
  • Lexington, Kentucky
  • +1 more
Jan 17, 2023

Borderline Personality Disorder Trial (Caplyta, Placebo)

Not yet recruiting
  • Borderline Personality Disorder
  • (no location specified)
May 16, 2022

Healthy Trial in Charleston (Focused Ultrasound Stimulation)

Not yet recruiting
  • Healthy
  • Focused Ultrasound Stimulation
  • Charleston, South Carolina
    Medical University of South Carolina
Mar 17, 2023

Treatment Resistant Depression, Depression, MDD Trial in Oxford (Ketamine Hydrochloride, No intervention ())

Recruiting
  • Treatment Resistant Depression
  • +2 more
  • Ketamine Hydrochloride
  • No intervention (placebo)
  • Oxford, United Kingdom
    Department of Psychiatry, University of Oxford
Mar 28, 2023

Ovarian Stimulation, Human Chorionic Gonadotropin, Oocyte Donors Trial in Thessaloniki (Dual trigger (human chorionic

Recruiting
  • Ovarian Stimulation
  • +2 more
  • Dual trigger (human chorionic gonadotropin plus GnRH-agonist)
  • GnRH-agonist only trigger
  • Thessaloniki, Greece
    Embryolab Fertility Clinic
Nov 20, 2023

MDD Trial in Basel (D-serine, Placebo)

Recruiting
  • Major Depressive Disorder
  • D-serine
  • Placebo
  • Basel, Baselstadt, Switzerland
    University of Basel, Department of Psychiatry (UPK)
Oct 31, 2022

Type1diabetes, Depressive Symptoms, MDD Trial (Glucose Clamp)

Completed
  • Type1diabetes
  • +2 more
  • Glucose Clamp
  • (no location specified)
Apr 29, 2022

Preemptive Analgesia, Dexmedetomidine, Ketamine Trial in Kafr Ash Shaykh (Dexmedetomidine, Ketamine, Magnesium sulphate)

Not yet recruiting
  • Preemptive Analgesia
  • +5 more
  • Kafr Ash Shaykh, Karelsheikh, Egypt
    Karelsheikh University Hospital
Apr 19, 2023

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

Alcohol Use Disorder Trial in New York (CI-581a, CI-581b, MBRP)

Recruiting
  • Alcohol Use Disorder
  • New York, New York
    NYSPI
Mar 29, 2022

Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)

Completed
  • Hair Diseases
  • +2 more
  • DA-OTC-002
  • Manaus, Brazil
    Hospital Oscar Nicolau
Oct 20, 2023

Glioblastoma Trial (Gabapentin, Sulfasalazine, Memantine)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Dec 15, 2022

Anesthesia, Dexmedetomidine, Aging Trial in Santiago (Dexmedetomidine, Placebo)

Recruiting
  • Anesthesia
  • +2 more
  • Santiago, Metropolitana, Chile
    Pontificia Universidad Catolica de Chile
Mar 13, 2022